In China, the prices of cyclopentane are generally steady for the month of October due to support from the stable cost of feedstock and fundamentally balanced supply against demand amid generally soft downstream activities and external market pressures.
On the cost side, the feedstock Cyclohexane price showed a narrow and relatively weak trading range throughout October. The market activity was moderate as the prices moved down with minor declines due to weak demand and periodic plant shutdowns by producers. Quotations by some suppliers were temporarily suspended, which limited the overall market momentum. In addition, Cyclohexane exports to South Korea and Vietnam were lower, reflecting the broader regional trade slowdown. The price of upstream benzene weakened in the month due to lower crude oil prices, soft supply-demand fundamentals, and weak downstream consumption. As Sinopec lowered its listed price for benzene, the cost pressure on cyclohexane—and by extension, cyclopentane—remained steady to low, giving little incentive for any upward price adjustment.
On the manufacturing and supply side, by the end of the third quarter, China’s industrial sector posted a moderate gain. Factory output and operational efficiency improved in many industries, including those involved with the production of chemicals and construction materials. Supply chains also stabilized somewhat, with lead times reduced and overall material availability increased in a number of key production centers. Better coordination between suppliers and normalizing logistics, after prior seasonal disruptions, helped drive this. In the case of Cyclopentane producers, consistent feedstock availability and predictable cost conditions assisted in stable output levels. With no significant supply disruptions or spikes in production costs, supply was balanced with demand, bolstering price stability throughout for Cyclopentane.
In the domestic market, the demand for Cyclopentane was relatively weak due to sluggish downstream activities. There were fewer active production days during the National Day holiday in early October, as many factories shut down. Downstream users, such as refrigerator, freezer, and insulation manufacturers, continued their "on-demand purchasing" strategy and only purchased the minimum amount of goods they needed. With limited support from seasonal inventory replenishment, overall purchasing interest remained lackluster for Cyclopentane. In the second half of the month, there was no big difference, since some terminal industries, including refrigerants and foaming agents, had a quiet trading atmosphere and lacked impetus for large-scale procurement of Cyclopentane.
In a nutshell, the price of Cyclopentane in China continued to remain firm throughout October 2025, underpinned by stable feedstock prices, unchanged supply conditions, and flat demand. Since cost drivers are weak and downstream sentiment is cautious, the Cyclopentane market maintains balance—and no turbulent price fluctuations in major trading regions have been recorded so far.
As per ChemAnalyst, market participants are expected to continue a conservative stance into November, closely monitoring both domestic consumption trends and feedstock movements around the world for cyclopentane future pricing cues.
